EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD

Catelyn R Coyle, Michael R Desjardins, Frank C Curriero, Jacqueline Rudolph, Jacquie Astemborski, Oluwaseun Falade-Nwulia iD, Gregory D Kirk, David L Thomas, Shruti H Mehta, Becky L Genberg

Journal of Viral Hepatitis · 2023

DOI: 10.1111/jvh.13864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2023. Verfasst von Catelyn R Coyle und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Drug Users, Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We evaluated geographic heterogeneity in hepatitis C virus (HCV) treatment penetration among people who inject drug (PWID) across Baltimore, MD since the advent of direct‐acting antivirals (DAAs) using space–time clusters of HCV viraemia. Using data from a community‐based cohort of PWID, the AIDS Linked to the IntraVenous Experience (ALIVE) study, we identified space–time clusters with higher‐than‐expected rates of HCV viraemia between 2015 and 2019 using scan statistics. We used Poisson regression to identify covariates associated with HCV viraemia and used the regression‐fitted values to detect adjusted space–time clusters of HCV viraemia in Baltimore city. Overall, in the cohort, HCV viraemia fell from 77% in 2015 to 64%, 49%, 39% and 36% from 2016 to 2019. In Baltimore city, the percentage of census tracts where prevalence of HCV viraemia was ≥85% dropped from 57% to 34%, 25%, 22% and 10% from 2015 to 2019. We identified two clusters of higher‐than‐expected HCV viraemia in the unadjusted analysis that lasted from 2015 to 2017 in East and West Baltimore and one adjusted cluster of HCV viraemia in West Baltimore from 2015 to 2016. Neither differences in age, sex, race, HIV status, nor neighbourhood deprivation were able to explain the significant space–time clusters. However, residing in a cluster with higher‐than‐expected viraemia was associated with age, sex, educational attainment and higher levels of neighbourhood deprivation. Nearly 4 years after DAAs became available, HCV treatment has penetrated all PWID communities across Baltimore city. While nearly all census tracts experienced improvements, change was more gradual in areas with higher levels of poverty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousDrug UsersHepatitis C, ChronicHepatitis CHumansHepacivirusAntiviral AgentsBaltimoreViremia

Stichwörter der Autor:innen

Baltimoredirect-acting antiviralsgeospatial clusteringhepatitis C viruspeople who inject drugs

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Merck & Co. Inc., Rahway, New Jersey, USA.
  • Spatial Science for Public Health Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Oluwaseun Falade-Nwulia

Förderung

  • NIDA NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Coyle, C. R., Desjardins, M. R., Curriero, F. C., Rudolph, J., Astemborski, J., Falade-Nwulia, O., Kirk, G. D., Thomas, D. L., Mehta, S. H., & Genberg, B. L. (2023). Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13864

Vancouver

Coyle CR, Desjardins MR, Curriero FC, Rudolph J, Astemborski J, Falade-Nwulia O, et al. Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD. Journal of Viral Hepatitis. 2023. doi:10.1111/jvh.13864

BibTeX
@article{Coyle2023,
  author = {Coyle, Catelyn R and Desjardins, Michael R and Curriero, Frank C and Rudolph, Jacqueline and Astemborski, Jacquie and Falade-Nwulia, Oluwaseun and Kirk, Gregory D and Thomas, David L and Mehta, Shruti H and Genberg, Becky L},
  title = {Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD},
  journal = {Journal of Viral Hepatitis},
  year = {2023},
  doi = {10.1111/jvh.13864}
}
Kostenlos starten →